Dubai’s 691,000 health tourists face Qatar’s 6-state GCC patient push

Dubai treated 691,000 health tourists in 2023, giving providers a measurable lead as Qatar joins a 6-state GCC contest for international patients.

For healthcare CEOs, CFOs and COOs, the immediate issue is commercial: Gulf providers are competing for self-pay patients who compare price, speed, clinician access and regulator-approved care pathways before booking treatment abroad.

Dubai has the numbers

Travel And Tour World reported on 20 June 2026 that Qatar is now positioned with Saudi Arabia, the UAE, Bahrain, Kuwait and Oman in the GCC race for medical travellers. The report tied demand to treatment costs in Europe and the US, a familiar sales point for Gulf operators that package access, English-speaking care and recovery logistics.

Dubai Health Authority (DHA) figures cited in the Dubai Health Investment Guide 2024 show 691,000 international health tourists in 2023 and healthcare spending above AED 1.03 billion. That was up from 674,000 health tourists and AED 992 million in spending in 2022, according to the same DHA guide.

• 111 healthcare providers were counted in DXH health tourism data for 2022.
• 69% of international patient visits went to polyclinics in the same DHA dataset.
• Dermatology, dental and gynaecology were among the top requested services.
• 140 airlines connected Dubai to 260 destinations, according to the DHA guide.

Regulation is part of the product

For COOs, the operating test is whether the international patient journey can withstand regulator review. In Dubai, DHA regulates licensed providers and runs the Dubai Health Experience (DXH) platform. In Abu Dhabi and Al Ain, the Department of Health Abu Dhabi (DOH) is the regulator. In Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah, providers answer to the Ministry of Health and Prevention (MOHAP).

The Dubai Health Investment Guide 2024 says DXH group members undergo evaluation, facility standards checks, on-site inspections and reviews by DHA’s Health Regulation Department. That process matters for hospitals and clinics that sell bundled international patient packages, because the offer depends on licensed professionals, documented consent, complaint handling and clear price communication.

"We aim to provide easy access to the highest quality of patient-centered care across various medical specialties." Mohamed Almheiri, Director, Health Tourism Department, DHA.

The Ministry of Economy and DHA also formalised sector coordination through a memorandum of understanding signed on 27 September 2022. The MoU was signed by Juma Mohammed Al Kait, Assistant Undersecretary at the Ministry of Economy, and Dr. Marwan Al Mulla, then CEO of DHA’s Health Regulation Sector, to support medical tourism flows and exchange expertise on intellectual property and patents.

What operators should watch in 2026

For CFOs, the number to remember is revenue per international patient. Dubai’s AED 1.03 billion in direct health tourism spending across 691,000 tourists in 2023 implies average healthcare spend of about AED 1,490 per visitor. That average favours high-volume outpatient services, and it limits how much hospitals can infer about cardiac, orthopaedic, fertility or oncology travel without clearer case-mix data.

For CEOs and marketing heads, Qatar’s entry into the GCC medical travel narrative means Dubai providers need more than airport access and hotel inventory. The Knight Frank Dubai Health Tourism Guide, produced with DHA and published on 4 February 2025, said Dubai ranked 16th on the Medical Tourism Index and cited demand for orthopaedic, infertility and dental care.

The next signal is whether DHA, DOH and MOHAP publish more comparable data on inbound patients, outcomes, pricing and complaints in 2026. Until then, UAE operators should treat GCC medical tourism as a patient-acquisition market with regulator risk attached. Providers with audited prices, faster scheduling, named clinicians, outcomes data and documented complaint pathways will have the clearer pitch to overseas patients and referral partners.